Blirt SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Blirt SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11194
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポーランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Blirt SA (Blirt) is a biotechnology company that produces specialty enzymes utilized in nucleic acid for purification and sequencing. The company offers recombinant protein and molecular biology products. It provides protein products such as proteinases, RNase inhibitors, reverse transciptases, polymerases, ligases, and other proteins. Blirt’s reagents include DNA and RNA isolation kits, real-time PCR mixes, PCR reagents, reverse transcription, enzymes and proteins, electrophoresis, and educational kits. The compay’s services include molecular biology and GLP analytical services, bio-analytical, genomic, contract manufacturing services, and biological research reagent manufacturing. It caters to pharmaceutical and biotech companies. Blirt is headquartered in Gdansk, Poland.

Blirt SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Blirt SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blirt SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blirt SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blirt SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Blirt SA, Medical Devices Deals, 2012 to YTD 2018 9
Blirt SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Blirt SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Blirt Enters into Agreement with Rhein Biotech for Cancer Vaccine 11
Licensing Agreements 12
Blirt Plans To Out-License Antifungal Assets 12
Equity Offering 13
Blirt to Raise USD0.3 Million in Private Placement of Series N Shares 13
Blirt Raises USD0.1 Million in Public Offering of Shares 14
Blirt to Raise USD0.8 Million in Private Placement of Series L Shares 15
Blirt to Raise Funds through Private Placement of Series A Warrants 16
Blirt SA – Key Competitors 17
Blirt SA – Key Employees 18
Blirt SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Blirt SA, Pharmaceuticals & Healthcare, Key Facts 2
Blirt SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blirt SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blirt SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blirt SA, Deals By Therapy Area, 2012 to YTD 2018 8
Blirt SA, Medical Devices Deals, 2012 to YTD 2018 9
Blirt SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Blirt Enters into Agreement with Rhein Biotech for Cancer Vaccine 11
Blirt Plans To Out-License Antifungal Assets 12
Blirt to Raise USD0.3 Million in Private Placement of Series N Shares 13
Blirt Raises USD0.1 Million in Public Offering of Shares 14
Blirt to Raise USD0.8 Million in Private Placement of Series L Shares 15
Blirt to Raise Funds through Private Placement of Series A Warrants 16
Blirt SA, Key Competitors 17
Blirt SA, Key Employees 18
Blirt SA, Other Locations 19
Blirt SA, Subsidiaries 19

List of Figures
Blirt SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Blirt SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Blirt SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Blirt SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Blirt SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blirt SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Blirt SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blirt SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Blirt SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Blirt SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitsui E&S Holdings Co., Ltd. (7003):企業の財務・戦略的SWOT分析
    Mitsui E&S Holdings Co., Ltd. (7003) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bando Chemical Industries, Ltd. (5195):企業の財務・戦略的SWOT分析
    Bando Chemical Industries, Ltd. (5195) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • JBCC Holdings Inc (9889):企業の戦略的SWOT分析
    JBCC Holdings Inc (9889) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析
    Summary MiMedx Group Inc (MiMedx) develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental …
  • Sumitomo Electric Industries, Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Electric Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Electric Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Valence Health-製薬・医療分野:企業M&A・提携分析
    Summary Valence Health is a healthcare company that provides healthcare services. The company offers solutions such as consulting, vision platform, quality measurement, cost and utilization, data collection, contract administration, managed services, and actuarial services. It provides health care s …
  • Hays plc:企業の戦略・SWOT・財務情報
    Hays plc - Strategy, SWOT and Corporate Finance Report Summary Hays plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • LPL Financial Holdings Inc (LPLA):企業の財務・戦略的SWOT分析
    LPL Financial Holdings Inc (LPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Mitsubishi Chemical Holdings Corporation:戦略・SWOT・企業財務分析
    Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Semma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Semma Therapeutics Inc (Semma Therapeutics) is a biotechnology company that develops cell replacement therapy for the treatment of diabetes. The company develops therapies using stem cells of the individuals with Type 1 diabetes to produce their own insulin that will regulate the blood sugar …
  • Stena Metall AB:企業の戦略・SWOT・財務分析
    Stena Metall AB - Strategy, SWOT and Corporate Finance Report Summary Stena Metall AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Otto Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Otto Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Otto Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the ope …
  • Central Japan Railway Co (9022):企業の財務・戦略的SWOT分析
    Central Japan Railway Co (9022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Burmeister & Wain Scandinavian Contractor AS-エネルギー分野:企業M&A・提携分析
    Summary Burmeister & Wain Scandinavian Contractor A/S (BWSC), a subsidiary of MESCO Denmark A/S, is a provider of tailor-made turnkey power plant solutions. It develops, operates and undertakes contracts for medium to large-scale power plants. The company handles projects for conventional fossil-fue …
  • Saab AB:企業の戦略・SWOT・財務情報
    Saab AB - Strategy, SWOT and Corporate Finance Report Summary Saab AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Cost Plus Inc:企業の戦略的SWOT分析
    Cost Plus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Marathon Petroleum Corporation:企業の戦略・SWOT・財務情報
    Marathon Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Marathon Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Anthera Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Anthera Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anthera Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Amgen Inc (AMGN):企業の財務・戦略的SWOT分析
    Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆